Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Predictive peripheral blood biomarker for checkpoint inhibitors

Predictive peripheral blood biomarker for checkpoint inhibitors

US Patent 11899017 · Granted Feb 13, 2024

Estimated economic value: $156,296,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions monovalent for CD28 binding and methods of use2024
Methods of treating systemic lupus erythematosus using a domain antibody directe2024
Nucleic acids encoding antagonistic CD40 monoclonal antibodies2023
Methods of treating autoimmune disease using a domain antibody directed against 2022
Methods of treating systemic lupus erythematosus using a domain antibody directe2022
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity2022
Antibody polypeptides that antagonize CD40L2021
Methods of treating immune diseases by administering antibody polypeptides that 2021
Compositions monovalent for CD28 binding and methods of use2021
Nucleic acids encoding antibody polypeptides that antagonize CD402020
Method of using antibody polypeptides that antagonize CD40 to treat IBD2019
Methods of treating immune diseases by administering antibody polypeptides that 2019